Search for Clinical Trial Results

Sponsored By

Birt-Hogg-Dube Syndrome - 5 Studies Found

Status Study
Recruiting Study Name: Assessment of Safety of Air Travel in Patients With Birt-Hogg-Dube Syndrome
Condition: Birt-Hogg-Dube Syndrome
Date: 2017-01-05
Interventions: Other: Non-Interventional Study
Completed Study Name: Topical Rapamycin for Fibrofolliculomas
Condition: Birt-Hogg-Dubé Syndrome
Date: 2009-06-25
Interventions:
  • Drug: Rapamycin Application of
Recruiting Study Name: Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer
Condition:
  • Renal Cancer
  • Chromophobe Renal Cell Carcinoma
  • Date: 2015-07-21
    Interventions: Drug: Everolimus Everolimus is a commercial agent and is supplied by Novartis.
Recruiting Study Name: Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
Condition:
  • Kidney Neoplasms
  • Kidney Cancer
  • Pneumothorax
  • Date: 2002-04-05
Recruiting Study Name: Prevalence of Spontaneous Pneumothorax in BHD
Condition: Spontaneous Pneumothorax
Date: 2016-01-23
Interventions:
  • Radiation: CT scan of the thorax